This histogram enumerates side effects from a completed 2020 Phase 4 trial (NCT04089982) in the Varenicline ARM group. Side effects include: Abnormal/Vivid Dreams with 17%, Dry Mouth with 17%, Nausea/Vomiting with 17%, Constipation with 17%, Dizziness/Lightheadedness with 17%.
2 Treatment Groups
Nicotine Patch + Placebo Tablet
1 of 2
Varenicline + Placebo Patch
1 of 2
204 Total Participants · 2 Treatment Groups
Primary Treatment: Varenicline · Has Placebo Group · Phase 4
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.